C2H
  • About C2H
    • Who we are
    • Members
    • Links
    • Access
  • What we do
    • Drug price setting
    • Necessity of evaluation
    • Concept of cost-effecitveness
    • Evaluation of costs
    • Evaluation of outcome
    • Example
    • Other countries (1)
    • Other countries (2)
    • Application in Japan
    • Roles of C2H
  • Results
    • Results (~2019.3)
    • Results (2019.4~)
  • Tools
    • Guideline and others
    • Related literatures
    • PBMs
    • Database
    • Abbreviations
  • Latest news
    • News
    • Events
    • Reports
  • For experts
  • For clinicians/citizens
  • Contact us
  • Japanese
  • Who we are
  • C2H Members
  • Links
  • Access

Links

Organizations (Domestic)


  • National Institute of Public Health
  • Ministry of Health, Labour and Welfare

Academic Societies and Organizations


  • HTAi
  • INAHTA
  • HTAsiaLink

Results of assessment/appraisal by HTA agency


  • NICE (England)
  • AWMSG (Wales)
  • SMC (Scotland)
  • CADTH CDR (Canada) [Prescription drugs]
  • CADTH pCODR (Canada) [Anticancer drugs]
  • INESSS (Québec, Canada)
  • PBAC (Australia)
  • PHARMAC (NZ)
  • NCPE (Ireland)
  • IQWiG (Germany)
  • G-BA (Germany) [in German]
  • HAS (France) [in French]
  • TLV (Sweden) [in Swedish]
  • NT council (Sweden) [in Swedish]
  • HITAP (Thailand)
  • ICER (US , NPO)
  • Terms of service
  • Privacy policy

Coryright © National Institute of Public Health.
All Rights Reserved.